Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Einstein

Showing results (121-130 of 198) with videos related to

Pageof 20
Sort By:
Human Vaccines & Immunotherapeutics|December 9, 2014
Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trialMark H Einstein, Peter Takacs, Archana Chatterjee, et al.
Blood|March 1, 1991
Monitoring of specific antibodies to human immunodeficiency virus structural proteins: clinical significanceJ P Allain, Y Laurian, M H Einstein, et al.
Sexually Transmitted Diseases|November 14, 2013
Use of the dye stain assay and ultraviolet light test for assessing vaginal insertion of placebo-filled applicators before and after sexMarla J Keller, Niall Buckley, Lauren L Katzen, et al.
Sexually Transmitted Diseases|November 14, 2013
Evaluation of 3 approaches for assessing adherence to vaginal gel application in clinical trialsAriane van der Straten, Helen Cheng, Barbara Mensch, et al.
Gynecologic Oncology|November 8, 2011
Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcomaMark H Einstein, Merieme Klobocista, June Y Hou, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 20, 2015
Association of High-Risk Human Papillomavirus with Genital Tract Mucosal Immune Factors in HIV-Infected WomenNiall Buckley, Ashley Huber, Yungtai Lo, et al.
Human Vaccines|August 18, 2009
Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 yearsMark H Einstein, Mira Baron, Myron J Levin, et al.
Gynecologic Oncology|September 15, 2016
In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gelAkiva P Novetsky, Marla J Keller, Ana Gradissimo, et al.
Aging Cell|March 28, 2008
Visceral adipose tissue modulates mammalian longevityRadhika Muzumdar, David B Allison, Derek M Huffman, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 2022
Quality Assurance in Clinical Trials Requiring Radiation Therapy in Sub-Saharan AfricaLilie L Lin, Ntokozo Ndlovu, Jessica Lowenstein, et al.
Pageof 20

Showing results (121-130 of 198) with videos related to

Sort By:
Pageof 20
Human Vaccines & Immunotherapeutics|December 9, 2014
Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trialMark H Einstein, Peter Takacs, Archana Chatterjee, et al.
Blood|March 1, 1991
Monitoring of specific antibodies to human immunodeficiency virus structural proteins: clinical significanceJ P Allain, Y Laurian, M H Einstein, et al.
Sexually Transmitted Diseases|November 14, 2013
Use of the dye stain assay and ultraviolet light test for assessing vaginal insertion of placebo-filled applicators before and after sexMarla J Keller, Niall Buckley, Lauren L Katzen, et al.
Sexually Transmitted Diseases|November 14, 2013
Evaluation of 3 approaches for assessing adherence to vaginal gel application in clinical trialsAriane van der Straten, Helen Cheng, Barbara Mensch, et al.
Gynecologic Oncology|November 8, 2011
Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcomaMark H Einstein, Merieme Klobocista, June Y Hou, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 20, 2015
Association of High-Risk Human Papillomavirus with Genital Tract Mucosal Immune Factors in HIV-Infected WomenNiall Buckley, Ashley Huber, Yungtai Lo, et al.
Human Vaccines|August 18, 2009
Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 yearsMark H Einstein, Mira Baron, Myron J Levin, et al.
Gynecologic Oncology|September 15, 2016
In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gelAkiva P Novetsky, Marla J Keller, Ana Gradissimo, et al.
Aging Cell|March 28, 2008
Visceral adipose tissue modulates mammalian longevityRadhika Muzumdar, David B Allison, Derek M Huffman, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 2022
Quality Assurance in Clinical Trials Requiring Radiation Therapy in Sub-Saharan AfricaLilie L Lin, Ntokozo Ndlovu, Jessica Lowenstein, et al.
Pageof 20